These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6412668)

  • 21. [Progressive myoclonic epilepsy secondary to Lafora's body disease].
    Potes T; Galicchio S; Rosso B; Besocke G; García MDC; Avalos JC
    Medicina (B Aires); 2018; 78(6):436-439. PubMed ID: 30504111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CSF oligoclonal bands, immunoglobulins, and viral antibodies in progressive myoclonus epilepsy.
    Iivanainen M; Leinikki P; Taskinen E; Shekarchi IC; Madden D; Sever J
    Arch Neurol; 1981 Apr; 38(4):206-8. PubMed ID: 6783017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype.
    Ganesh S; Delgado-Escueta AV; Suzuki T; Francheschetti S; Riggio C; Avanzini G; Rabinowicz A; Bohlega S; Bailey J; Alonso ME; Rasmussen A; Thomson AE; Ochoa A; Prado AJ; Medina MT; Yamakawa K
    Hum Mol Genet; 2002 May; 11(11):1263-71. PubMed ID: 12019207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropharmacology of progressive myoclonus epilepsy: response to 5-hydroxy-L-tryptophan.
    Pranzatelli MR; Tate E; Huang Y; Haas RH; Bodensteiner J; Ashwal S; Franz D
    Epilepsia; 1995 Aug; 36(8):783-91. PubMed ID: 7543407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FAME 3: a novel form of progressive myoclonus and epilepsy.
    Carr JA; van der Walt PE; Nakayama J; Fu YH; Corfield V; Brink P; Ptacek L
    Neurology; 2007 Apr; 68(17):1382-9. PubMed ID: 17452583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myoclonus, cerebellar disorder, neuropathy, mitochondrial myopathy, and ACTH deficiency.
    Sasaki H; Kuzuhara S; Kanazawa I; Nakanishi T; Ogata T
    Neurology; 1983 Oct; 33(10):1288-93. PubMed ID: 6310438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of degenerative type of progressive myoclonus epilepsy].
    Tateno A; Morisawa K; Koya N; Fujioka Y; Ikeda K
    No To Hattatsu; 1993 Jan; 25(1):81-6. PubMed ID: 8416700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium valproate and clonazepam in the treatment of intractable epilepsy.
    Lance JW; Anthony M
    Arch Neurol; 1977 Jan; 34(1):14-7. PubMed ID: 401638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conventional and novel anti-seizure medications reveal a particular role for GABA
    Polet SS; de Koning TJ; Lambrechts RA; Tijssen MAJ; Sibon OCM; Gorter JA
    Epilepsy Res; 2024 Jul; 203():107380. PubMed ID: 38781737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lafora's disease and brain calcifications.
    Oster S; Reske-Nielsen E; Bruun I
    Acta Neuropathol; 1988; 76(5):532-8. PubMed ID: 3142202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The gene for progressive myoclonus epilepsy of the Lafora type maps to chromosome 6q.
    Serratosa JM; Delgado-Escueta AV; Posada I; Shih S; Drury I; Berciano J; Zabala JA; Antúnez MC; Sparkes RS
    Hum Mol Genet; 1995 Sep; 4(9):1657-63. PubMed ID: 8541857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lafora's disease: a possible diagnosis of juvenile dementia].
    Dias-Tosta E; Vieira LF; Alves A; Miziara HL
    Arq Neuropsiquiatr; 1995 Sep; 53(3-A):455-63. PubMed ID: 8540822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lafora's disease. Comparison of inclusion bodies in skin and in brain.
    Busard BL; Renier WO; Gabreëls FJ; Jaspar HH; van Haelst UJ; Slooff JL
    Arch Neurol; 1986 Mar; 43(3):296-9. PubMed ID: 3004400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post anoxic action myoclonus.
    Larner AJ; Heafield MT
    J R Soc Med; 1993 May; 86(5):310. PubMed ID: 8505765
    [No Abstract]   [Full Text] [Related]  

  • 35. A case of Lafora's disease associated with cardiac arrhythmia.
    Oksel F; Tekgül H; Genç S; Ozyürek R; Akalin T; Tütütüncüoğlu S
    J Child Neurol; 1999 Nov; 14(11):745-6. PubMed ID: 10593553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressive myoclonus epilepsy: genetic and nosological aspects with special reference to 107 Finnish patients.
    Norio R; Koskiniemi M
    Clin Genet; 1979 May; 15(5):382-98. PubMed ID: 109240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IRF2BPL as a novel causative gene for progressive myoclonus epilepsy.
    Gardella E; Michelucci R; Christensen HM; Fenger CD; Reale C; Riguzzi P; Pasini E; Albini-Riccioli L; Papa V; Foschini MP; Cenacchi G; Furia F; Marjanovic D; Hammer TB; Møller RS; Rubboli G
    Epilepsia; 2023 Aug; 64(8):e170-e176. PubMed ID: 37114479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive dementia and epilepsy in a young adult: unusual intraneuronal inclusions.
    Yerby MS; Shaw CM; Watson JM
    Neurology; 1986 Jan; 36(1):68-71. PubMed ID: 3001585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Semi-late onset and rapidly progressive case of Lafora's disease with predominant cognitive symptoms.
    Genton P; Borg M; Vigliano P; Pellissier JF; Roger J
    Eur Neurol; 1989; 29(6):333-8. PubMed ID: 2514103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L-tryptophan-carbidopa trial in patients with long-standing progressive myoclonus epilepsy.
    Leino E; MacDonald E; Airaksinen MM; Riekkinen PJ; Salo H
    Acta Neurol Scand; 1981 Aug; 64(2):132-41. PubMed ID: 6172951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.